Critical Review: First Choice Healthcare Solutions (FCHS) & Its Rivals

First Choice Healthcare Solutions (OTCMKTS: FCHS) is one of 21 public companies in the “Medical laboratories” industry, but how does it contrast to its competitors? We will compare First Choice Healthcare Solutions to similar businesses based on the strength of its valuation, dividends, profitability, earnings, analyst recommendations, risk and institutional ownership.

Earnings & Valuation

This table compares First Choice Healthcare Solutions and its competitors gross revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
First Choice Healthcare Solutions $28.74 million -$3.88 million -7.93
First Choice Healthcare Solutions Competitors $1.13 billion $76.65 million 353.09

First Choice Healthcare Solutions’ competitors have higher revenue and earnings than First Choice Healthcare Solutions. First Choice Healthcare Solutions is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Profitability

This table compares First Choice Healthcare Solutions and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
First Choice Healthcare Solutions -12.79% -25.35% -15.86%
First Choice Healthcare Solutions Competitors -93.52% -118.89% -36.86%

Risk & Volatility

First Choice Healthcare Solutions has a beta of -0.53, indicating that its stock price is 153% less volatile than the S&P 500. Comparatively, First Choice Healthcare Solutions’ competitors have a beta of 1.29, indicating that their average stock price is 29% more volatile than the S&P 500.

Institutional and Insider Ownership

0.1% of First Choice Healthcare Solutions shares are owned by institutional investors. Comparatively, 49.6% of shares of all “Medical laboratories” companies are owned by institutional investors. 30.8% of First Choice Healthcare Solutions shares are owned by insiders. Comparatively, 17.5% of shares of all “Medical laboratories” companies are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Analyst Ratings

This is a summary of recent ratings for First Choice Healthcare Solutions and its competitors, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
First Choice Healthcare Solutions 0 1 2 0 2.67
First Choice Healthcare Solutions Competitors 121 521 612 31 2.43

First Choice Healthcare Solutions presently has a consensus target price of $2.50, suggesting a potential upside of 110.08%. As a group, “Medical laboratories” companies have a potential downside of 6.33%. Given First Choice Healthcare Solutions’ stronger consensus rating and higher possible upside, equities research analysts plainly believe First Choice Healthcare Solutions is more favorable than its competitors.

Summary

First Choice Healthcare Solutions beats its competitors on 7 of the 13 factors compared.

About First Choice Healthcare Solutions

First Choice Healthcare Solutions, Inc., through its subsidiaries, provides healthcare services in the United States. Its network of non-physician-owned medical centers offer musculoskeletal and rehabilitative care services specializing in orthopaedics, spine surgery, interventional pain management, and ambulatory surgical care. The company also provides ancillary and diagnostic services comprising magnetic resonance imaging, X-ray, durable medical equipment, and physical/occupational therapy. In addition, it subleases 29,629 square feet of commercial office space to affiliated and nonaffiliated tenants. The company is headquartered in Melbourne, Florida.

Receive News & Ratings for First Choice Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for First Choice Healthcare Solutions and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply